Antiviral resistance and direct-acting antiviral agents for HCV

JOURNAL ARTICLE published 2012 in Antiviral Therapy

Authors: Amanda L Aloia | Stephen Locarnini | Michael R Beard

Treatment of Acute HCV Infection in HIV-Positive Patients: Experience from a Multicentre European Cohort

JOURNAL ARTICLE published February 2010 in Antiviral Therapy

Authors: Martin Vogel | Stéphanie Dominguez | Sanjay Bhagani | Alex Azwa | Emma Page | Marguerite Guiguet | Marc-Antoine Valantin | Christine Katlama | Jürgen K Rockstroh | Mark Nelson

The science of direct-acting antiviral and host-targeted agent therapy

JOURNAL ARTICLE published 2012 in Antiviral Therapy

Authors: Jean-Michel Pawlotsky

Effect of Abacavir on Acute Changes in Biomarkers Associated with Cardiovascular Dysfunction

JOURNAL ARTICLE published May 2012 in Antiviral Therapy

Authors: Pragna Patel | Tim Bush | Turner Overton | Jason Baker | John Hammer | Erna Kojic | Lois Conley | Keith Henry | John T Brooks | the SUN Study Investigators

Evidence of a Significant Role for Fas-Mediated Apoptosis in HCV Clearance during Pegylated Interferon plus Ribavirin Combination Therapy

JOURNAL ARTICLE published April 2011 in Antiviral Therapy

Authors: Leonardo L Schiavon | Janaína L Narciso-Schiavon | Roberto J Carvalho-Filho | Juliana P Sampaio | Philipe N El Batah | Genimari A Silva | Cláudia T Carvente | Antonio Eduardo B Silva | Maria Lucia G Ferraz

Potential threat of drug-resistant and vaccine-escape HBV mutants to public health

JOURNAL ARTICLE published 2010 in Antiviral Therapy

Authors: Chong-Gee Teo | Stephen A Locarnini

Distinct Hepatitis C virus Kinetics in HIV-Infected Patients Treated with Ribavirin plus Either Pegylated Interferon α2a or α2b

JOURNAL ARTICLE published May 2008 in Antiviral Therapy

Authors: Eugenia Vispo | Pablo Barreiro | Sonia Rodríguez-Nóvoa | Judit Morello | Pablo Labarga | Luz Martín-Carbonero | Ivana Maida | Pilar García-Gascó | Vincent Soriano

Providing access to high-quality, low-cost medicines across low and middle-income countries (LMICs), working with governments and generic manufacturers around the globe - A business case

JOURNAL ARTICLE published April 2022 in Antiviral Therapy

Authors: Gregg Alton | Clifford Samuel | Anand Reddi

Very Late HCV Relapse following Triple Therapy for Hepatitis C

JOURNAL ARTICLE published October 2014 in Antiviral Therapy

Authors: Pablo Barreiro | Eugenia Vispo | Ivana Maida | Antonio Aguilera | José V Fernández-Montero | Carmen de Mendoza | Pablo Labarga | Vincent Soriano

First-line Highly Active Antiretroviral Regimens in 2001–2002 in the French Hospital Database on HIV: Combination Prescribed and Biological Outcomes

JOURNAL ARTICLE published April 2007 in Antiviral Therapy

Authors: Valérie Potard | David Rey | Saadia Mokhtari | Véronique Frixon-Marin | Christian Pradier | Willy Rozenbaum | Françoise Brun-Vezinet | Dominique Costagliola | the French Hospital Database on HIV, ANRS C04

Prevalence and clinical implications of insertions in the HIV-1 p6^Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy

JOURNAL ARTICLE published February 2003 in Antiviral Therapy

Authors: Zabrina L Brumme | Keith J Chan | Winnie WY Dong | Brian Wynhoven | Theresa Mo | Robert S Hogg | Julio SG Montaner | Michael V O'Shaughnessy | P Richard Harrigan

Long-Term Foscarnet Therapy Remodels Thymidine Analogue Mutations and Alters Resistance to Zidovudine and Lamivudine in HIV-1

JOURNAL ARTICLE published April 2007 in Antiviral Therapy

Authors: Sofie Mathiesen | Elisabeth Dam | Birgit Roge | Louise Bruun Joergensen | Alex Lund Laursen | Jan Gerstoft | Francois Clavel

Real-life findings on the impact of the COVID-19 pandemic on HIV care

JOURNAL ARTICLE published May 2021 in Antiviral Therapy

Authors: Arturo Ciccullo | Gianmaria Baldin | Alberto Borghetti | Simona Di Giambenedetto

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-Nucleoside Polymerase Inhibitor

JOURNAL ARTICLE published May 2018 in Antiviral Therapy

Authors: Laetitia Canini | Annabelle Lemenuel-Diot | Barbara J Brennan | Patrick F Smith | Alan S Perelson

Antiviral Therapy of Haemorrhagic Fevers and Arbovirus Infections

JOURNAL ARTICLE published February 1998 in Antiviral Therapy

Authors: Mike Bray | John Huggins

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment

JOURNAL ARTICLE published July 2015 in Antiviral Therapy

Authors: Tushar Garimella | Reena Wang | Wen-Lin Luo | Carey Hwang | Diane Sherman | Hamza Kandoussi | Thomas C Marbury | Harry Alcorn | Richard Bertz | Marc Bifano

The Host–pathogen Interaction during HBV Infection: Immunological Controversies

JOURNAL ARTICLE published April 2010 in Antiviral Therapy

Authors: Antonio Bertoletti | Mala K Maini | Carlo Ferrari

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

JOURNAL ARTICLE published October 2011 in Antiviral Therapy

Authors: the ANRS AC11 HCV Group | Sophie Vallet | Florent Viron | Cecile Henquell | Helene Le Guillou-Guillemette | Giséle Lagathu | Florence Abravanel | Pascale Trimoulet | Patrick Soussan | Evelyne Schvoerer | Arielle Rosenberg | Stephanie Gouriou | Philippe Colson | Jacques Izopet | Christopher Payan

Changing strategies for hepatitis C testing

JOURNAL ARTICLE published 2012 in Antiviral Therapy

Authors: Chong Gee Teo

Resistance data in the ARTEN trial

JOURNAL ARTICLE published 2011 in Antiviral Therapy

Authors: Vincent Soriano | the ARTEN Investigators